I don't think we'll see anything close to 2021 in terms of that level of mania - simply because liquidity broadly has dropped by 90% since then, based on personal savings rate data - as the COVID stimulus money is pretty much exhausted. also, with rates up so much, credit is significantly tighter. That said, the GME, AMC and FFIE spikes were pretty incredible - and i don't understand it. Don't get me wrong, i'd love to see this run like it did in 2021 - if this thing spiked to $3 or $5, I'd unload my position pretty quickly :). But, i think it's highly unlikely in the near or intermediate term.
The real question is whether or not we'll see a reputable partner step in, per Jay's comments. That would be the biggest thing in the history of this company - as it would finally validate our drug, with an experienced player committing to Leronlimab.
Don't know why he would mention it if something wasn't close. I guess we'll see.
News 
Market Data 
Discover 
AI
